| Budget Amount *help |
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 2016: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2015: ¥1,200,000 (Direct Cost: ¥1,200,000)
|
|---|
| Outline of Annual Research Achievements |
Understanding the survival control mechanism of long-lived, antibody-producing cells and memory B cells at the germinal center (GC) is required for developing a effective vaccine against various infectious diseases including influenza viruses. It is unclear whether enhanced autophagy alters GC B cell differentiation. Rubicon, an autophagy suppressor, was up-regulated in activated B cells, suggesting that Rubicon may suppress autophagy in B cells. To address these questions, we generated pan-B cell- and GC-B cell-specific Rubicon-mutant mouse, respectively. A decrease in antigen-specific high-affinity antibody production and an increase in autoantibody such as anti-DNA antibody were found in Rubicon-mutant mice, suggesting that Rubicon may play a role in the selection of antigen-specific B cell. However, a small-molecular-weight protein that seems to be a Rubicon isoform was found in Rubicon-mutant B cells, suggesting that deletion of the Rubicon gene is incomplete. Thus, it is necessary to confirm the present results and clarify the function of each isoform of Rubicon with the complete Rubicon-deficient mouse. On the other hand, we unexpectedly found that CD40 signal specifically induced the secretion of LC3-II containing exosomes, suggesting that CD40 signal is involved in secretory autophagy. In addition, such secretion was enhanced in the Rubicon-mutant cells. CD40 is an essential molecule during B cell-T cell interaction, and further study of CD40-induced secretory autophagy may reveal a novel mechanism of lymphocyte interaction via secretory autophagy or exosome.
|
